Eif2B5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | EIF2B5 |
|---|---|
| Full Name | Eukaryotic Translation Initiation Factor 2B Subunit Epsilon |
| Chromosomal Location | 3q27.2 |
| NCBI Gene ID | 9451 |
| OMIM | 603951 |
| Ensembl ID | ENSG00000145191 |
| UniProt ID | P05198 |
| Associated Diseases | Vanishing White Matter Disease, Leukoencephalopathy |
EIF2B5 (Eukaryotic Translation Initiation Factor 2B Subunit Epsilon) is a critical gene encoding one of the five subunits of eIF2B, the guanine nucleotide exchange factor that recycles eIF2-GDP to eIF2-GTP. This process is essential for translational initiation in all eukaryotic cells.
EIF2B5 mutations are associated with vanishing white matter disease (VWM), an autosomal recessive leukoencephalopathy. The gene is ubiquitously expressed with high levels in brain white matter.
EIF2B5 encodes the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2B), the guanine nucleotide exchange factor (GEF) essential for protein synthesis initiation. The eIF2B complex catalyzes the exchange of GDP for GTP on eIF2, regenerating the active ternary complex required for translation initiation[1].
The epsilon subunit is the largest and most catalytically important subunit of eIF2B. It contains the catalytic core responsible for GEF activity. The eIF2B complex serves as the master regulator of the integrated stress response (ISR), where cellular stress leads to phosphorylation of eIF2alpha, which allosterically inhibits eIF2B, reducing global protein synthesis while upregulating stress-response genes including ATF4, CHOP, and GADD34[2].
EIF2B5 is one of the most frequently mutated genes in vanishing white matter disease (VWM). Over 60 pathogenic variants have been identified in this gene. VWM is an autosomal recessive leukodystrophy characterized by progressive cerebellar ataxia, spasticity, optic atrophy, and cognitive decline. MRI reveals symmetric white matter abnormalities with cystic degeneration[3].
The pathophysiology involves partial loss of eIF2B function, impairing the integrated stress response in glial cells. This is particularly detrimental to oligodendrocytes, which require robust protein homeostasis for continuous myelin production and maintenance. Studies show that cells with EIF2B5 mutations exhibit increased sensitivity to ER stress and impaired stress-induced translational reprogramming[4].
EIF2B5 is ubiquitously expressed with the highest expression in brain tissue. Within the CNS, it is expressed in oligodendrocytes, astrocytes, and neurons. The protein localizes to the cytoplasm where it participates in translation initiation. Its expression pattern correlates with regions most affected in VWM, particularly cerebral white matter[5].
The study of Eif2B5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.